PROK2 and COVID-19: Schirinzi et al., research study investigated the activity of two inflammatory pathways, SP and Prokineticin-2 (PK2), within the olfactory neurons (ONs) of patients to understand the mechanisms of persistent olfactory dysfunction (OD) post-COVID-19.